Home > Inhibitors & Agonists > GPCR > Prostaglandin Receptor
Cat. No. Product name CAS No.
DC9867 prostaglandin D2(PGD2) inhibitor

A small molecule compound of prostaglandin D2(PGD2) inhibitor.

DC12213 AGN 210676 (Simenepag)

AGN 210676 is a selective prostaglandin EP2 agonist extracted from patent US20070203222A1, Compound example 23, has an EC50 of 5 nM.

DC12230 AM211 Featured

AM211 is a potent, selective and orally bioavailable prostaglandin D2 (PGD2) receptor type 2 (DP2) antagonist

DC6310 AMG 853(AMG853;Vidupiprant)

AMG 853 is novel a CRTH2 and DP Dual Antagonist.

DC11174 ASP7657 Featured

ASP7657 (ASP-7657) is a potent, selective, orally active prostaglandin EP4 receptor antagonist with Ki values of 6.02 nM and 2.21 nM for rat and human EP4 receptors, resepctively.

DC7364 AT-56 Featured

AT-56 is a selective, competitive, and highly bioavailable inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) with a Ki value of 75 µM.

DC7572 AZD1981 Featured

AZD1981 is a potent, selective CRTh2 (DP2) receptor antagonist with IC50 of 4 nM, showing >1000-fold selectivity over more than 340 other enzymes and receptors, including DP1

DCAPI1079 Bimatoprost Featured

Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.

DC10847 CAY10441(RO1138452) Featured

CAY10441 is a Selective prostacyclin IP receptor antagonist.

DC12099 CAY10595

CAY10595 is a potent CRTH2/DP2 receptor antagonist that binds to the human receptor with a Ki of 10 nM.

DCAPI1545 Cloprostenol sodium

Cloprostenol Sodium is a synthetic F series prostaglandin that functions as a potent agonist towards the PGF2αR (FP receptor). It is known that Cloprostenol Sodium is less selective than other agonists such as fluprostenol, however it displays more potenc

DC9303 Taprenepag(CP-544326) Featured

CP-544326 is a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.

DC11154 CR6086

CR6086 (CR-6086) is a potent, selective prostaglandin E2 receptor 4 (EP4) antagonist with Ki of 16.6 nM (hEP4 receptor), inhibits PGE2-stimulated cAMP production with IC50 of 22 nM.

DC9863 Dinoprost Featured

Dinoprost(Prostaglandin F2α) is a naturally occurring prostaglandin used in medicine to induce labor and as an abortifacient.

DC10563 E-7046 Featured

E7046 is an orally bioavailable and specific EP4 antagonist, with IC50 of 13.5 nM and Ki of 23.14 nM, exhibiting anti-tumor activities.

DC9016 Etamsylate

Ethamsylate is a haemostatic drug, also inhibits biosynthesis and action of those prostaglandins.

DC9685 Evatanepag (CP-533536) Featured

Evatanepag (CP-533536) is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.

DC11278 Fevipiprant Featured

Fevipiprant(QAW039) is a selective, potent, reversible competitive CRTh2 antagonist with an in vitro dissociation constant KD value of 1.1nM at the CRTh2 receptor and an IC50 value of 0.44 nM for inhibition of PGD2-induced eosinophil shape change.

DC8266 GW-627368X Featured

GW 627368X is a selective prostanoid EP4 receptor competitive antagonist with additional affinity at TP receptors (pKi values are 7.0 and 6.8 in competition radioligand bioassays).

DC11377 L-826,266

L-826,266 is a potent and selective competitive antagonist of the prostaglandin E2 receptor subtype EP3 (Ki = 0.8 nM).

DC8635 Latanoprost Featured

Latanoprost is a prodrug (isopropyl ester) of 17-phenyl-13,14-dihydro prostaglandin F2α.

DC8249 MF498

MF498 is a novel and selective E prostanoid receptor 4 (EP4) inhibitor, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.

Page 1 / Total 5 FirstPrevNextLastGoto